Researchers from the Icahn School of Medicine at Mount Sinai say they have developed a RNA and DNA sequencing platform that benefits late-stage and...
Day: 10 August 2018
Lenalidomide ‘best maintenance option’ for multiple myeloma
Lenalidomide maintenance improved PFS and OS among patients with newly diagnosed multiple myeloma compared with other maintenance treatments,...
Resilience Important Aspect of Improved QOL for Myeloma
A high level of resilience—or a person’s ability to adapt to adversity—was associated with a better mental and physical health-related quality of...